US › Healthcare

Telomir Pharmaceuticals, Inc. Common Stock (TELO)

US · Healthcare · Biotechnology

$1.15-7.26%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-990,947
Profit YoY
+54.5%
EPS
$-0.03

Key statistics

Market cap
$83.2M
Forward P/E
0.0
P/B
16.84
Book value
$0.14
EPS (TTM)
$-0.29
52-week high
$2.09
52-week low
$0.89
50-day MA
$1.24
200-day MA
$1.31
Beta
-0.24

Analyst view

with an average price target of $15.50.

Shareholding

Insiders
45.55%
Institutions
3.28%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC1.45%
BlackRock Inc0.42%
Geode Capital Management, LLC0.36%
Vanguard Fiduciary Trust Co0.20%
Millennium Management LLC0.19%
State Street Corp0.09%
Bank of New York Mellon Corp0.07%
Suncoast Equity Management, LLC0.07%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Telomir Pharmaceuticals, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.